Press Releases


  • MHI and AstraZeneca to screen samples for cardiovascular and diabetes genetic traits

    May 13, 2015

    The Montreal Heart Institute (MHI) today announced a collaboration with AstraZeneca, to search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes, their complications and treatment outcomes.

    Read more

  • The Institute Biobank Celebrates its 20,000th Participant

    February 4, 2015

    Audrey Sirois, a 26-year-old patient, has become the 20,000th participant in the Montreal Heart Institute Biobank. Eventually, the Biobank will help the Institute's specialists and researchers better understand the genetic bases and other risk factors of cardiovascular disease.

    Read more

  • The Effect of Statins Influenced by Gene Profiles

    2014, October 28, 2014

    The Montreal Heart Institute Research Centre is once again pushing the limits of knowledge in personalized medicine. A meta-analysis combining the results of several pharmacogenomic studies and involving over 40,000 research subjects now makes it possible to demonstrate a different response to statins according to the patient's gene profile.

    Read more

  • Fish oil supplements have little effect on irregular heartbeat

    2014, October 14, 2014

    High doses of fish oil supplements, rich in omega-3 fatty acids, do not reduce atrial fibrillation, a common type of irregular heartbeat in which the heart can beat as fast as 150 beats a minute. The results of the AFFORD trial led by the Montreal Heart Institute were published in the Journal of the American College of Cardiology on October 7th.

    Read more

  • The Montreal Heart Institute Honours its Builders

    2014, March 25, 2014

    On March 25, as part of its 60th anniversary celebrations, the Montreal Heart Institute (MHI) honoured three of its builders: internationally renowned cardiologists Dr. Paul David, founder of the MHI, and Dr. Martial Bourassa, first director of the Research Centre, as well as Mr. J.-Louis Lévesque, philanthropist. The event was held at Maison Birks, a partner of the MHI's 60th anniversary celebrations.

    Read more

  • Dr Stanley Nattel receives honorary doctorate from the University of Szeged in Hungary

    2013, November 26, 2013

    Dr. Stanley Nattel, clinical cardiologist and Director of the Electrophysiology Research Program at the Research Centre of the Montreal Heart Institute (MHI), has received a prestigious Doctorem Honoris Causa from the University of Szeged in Hungary, one of the prominent medical schools of Europe.

    Read more

  • Heart valve repair or replacement: new findings will have a major impact on surgical practice

    2013, November 18, 2013

    A study published today in The New England Journal of Medicine and presented at the American Heart Association's Scientific Sessions 2013 marks a decisive step in the practice of heart surgery. A group of North American researchers compared two types of heart surgery to treat mitral valve failure, a very common heart defect that is estimated to affect approximately one out of five people over the age of 55. The study results seem to indicate that mitral valve replacement provides longer lasting protection than mitral valve repair.

    Read more

  • Cutting-edge genetic testing identifies inherited risk for enlarged heart

    2013, October 19, 2013

    A study presented today at the Canadian Cardiovascular Congress has identified the genetic mutations that account for a significant proportion of cases of familial dilated cardiomyopathy (DCM), a disease affecting thousands of Canadians.

    Read more

  • Montreal combo plate cuts weight and health risks in obese individuals

    2013, October 18, 2013

    A lifestyle program focused on high-intensity interval training combined with nutritional counselling on the Mediterranean diet have shown dramatic results for improving the heart health of people with abdominal obesity, finds a study released at the Canadian Cardiovascular Congress.

    Read more

  • A new approach to treat the most common heart valve disease in Western countries

    2013, July 18, 2013

    A study conducted by the team of Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute (MHI), has led to the discovery of a new approach to treat aortic valve stenosis through the administration of a compound that prevents valve deterioration and can even reverse the progression of the disease.

    Read more